Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud

FierceBiotech Radio

Fierce editors discuss how concerns about drug pricing have affected biopharma companies large and small, the latest threat to the biotech bubble, and Bristol-Myers Squibb's interesting televisual choices.